Crossmark Global Holdings’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.5M | Buy |
146,708
+694
| +0.5% | +$60.7K | 0.17% | 134 |
|
|
2026
Q1 | $12.4M | Sell |
146,014
-7,554
| -5% | -$673K | 0.18% | 132 |
|
|
2025
Q4 | $12.1M | Sell |
153,568
-37,096
| -19% | -$2.91M | 0.17% | 138 |
|
|
2025
Q3 | $15.2M | Buy |
190,664
+3,517
| +2% | +$300K | 0.23% | 104 |
|
|
2025
Q2 | $17M | Buy |
187,147
+2,170
| +1% | +$198K | 0.27% | 83 |
|
|
2025
Q1 | $17.3M | Buy |
184,977
+11,146
| +6% | +$998K | 0.31% | 79 |
|
|
2024
Q4 | $15.8M | Buy |
173,831
+7,105
| +4% | +$678K | 0.29% | 81 |
|
|
2024
Q3 | $17.3M | Buy |
166,726
+96,680
| +138% | +$9.85M | 0.31% | 73 |
|
|
2024
Q2 | $6.8M | Sell |
70,046
-5,099
| -7% | -$470K | 0.13% | 183 |
|
|
2024
Q1 | $6.77M | Sell |
75,145
-5,815
| -7% | -$493K | 0.13% | 184 |
|
|
2023
Q4 | $6.45M | Buy |
80,960
+13,315
| +20% | +$1M | 0.13% | 182 |
|
|
2023
Q3 | $4.7M | Sell |
67,645
-643
| -0.9% | -$48.1K | 0.11% | 221 |
|
|
2023
Q2 | $5.16M | Sell |
68,288
-3,334
| -5% | -$258K | 0.11% | 214 |
|
|
2023
Q1 | $5.38M | Sell |
71,622
-975
| -1% | -$72.5K | 0.13% | 198 |
|
|
2022
Q4 | $5.72M | Buy |
72,597
+3,522
| +5% | +$264K | 0.14% | 182 |
|
|
2022
Q3 | $4.85M | Sell |
69,075
-742
| -1% | -$58.2K | 0.13% | 188 |
|
|
2022
Q2 | $5.59M | Buy |
69,817
+640
| +0.9% | +$50K | 0.15% | 174 |
|
|
2022
Q1 | $5.25M | Buy |
69,177
+2,590
| +4% | +$205K | 0.12% | 202 |
|
|
2021
Q4 | $5.68M | Sell |
66,587
-160
| -0.2% | -$12.5K | 0.12% | 184 |
|
|
2021
Q3 | $5.04M | Buy |
66,747
+1,028
| +2% | +$81.6K | 0.12% | 192 |
|
|
2021
Q2 | $5.35M | Buy |
65,719
+527
| +0.8% | +$43.1K | 0.13% | 176 |
|
|
2021
Q1 | $5.14M | Buy |
65,192
+667
| +1% | +$52.3K | 0.13% | 180 |
|
|
2020
Q4 | $5.52M | Sell |
64,525
-3,482
| -5% | -$288K | 0.14% | 168 |
|
|
2020
Q3 | $5.25M | Sell |
68,007
-1,338
| -2% | -$102K | 0.15% | 163 |
|
|
2020
Q2 | $5.08M | Buy |
69,345
+4,427
| +7% | +$314K | 0.15% | 154 |
|
|
2020
Q1 | $4.31M | Buy |
64,918
+714
| +1% | +$50.4K | 0.15% | 158 |
|
|
2019
Q4 | $4.42M | Sell |
64,204
-252
| -0.4% | -$17.2K | 0.12% | 194 |
|
|
2019
Q3 | $4.74M | Sell |
64,456
-7,428
| -10% | -$539K | 0.14% | 179 |
|
|
2019
Q2 | $5.15M | Sell |
71,884
-423
| -0.6% | -$30K | 0.14% | 174 |
|
|
2019
Q1 | $4.96M | Sell |
72,307
-2,376
| -3% | -$153K | 0.14% | 179 |
|
|
2018
Q4 | $4.45M | Sell |
74,683
-12,913
| -15% | -$808K | 0.14% | 181 |
|
|
2018
Q3 | $5.87M | Sell |
87,596
-6,620
| -7% | -$441K | 0.15% | 164 |
|
|
2018
Q2 | $6.11M | Sell |
94,216
-4,292
| -4% | -$281K | 0.16% | 146 |
|
|
2018
Q1 | $7.06M | Sell |
98,508
-27,343
| -22% | -$1.97M | 0.18% | 136 |
|
|
2017
Q4 | $9.49M | Buy |
125,851
+5,524
| +5% | +$403K | 0.23% | 104 |
|
|
2017
Q3 | $8.77M | Buy |
+120,327
| New | +$8.67M | 0.23% | 110 |
|
|
2016
Q3 | $8.77M | Buy |
+120,327
| New | +$8.9M | 0.23% | 110 |
|
Other funds holding CL
SP
PAM
CIM
AAMU
EOJOAM
OIAM
AIM
Crossmark Global Holdings's CL Position: Q2 2026 in Review
Crossmark Global Holdings increased its Colgate-Palmolive (CL) stake by 0.48% in Q2 2026, buying an estimated $60.7K and bringing the position to 146,708 shares worth $13.5M. The position accounts for 0.17% of the portfolio, ranked #134.
Crossmark Global Holdings first reported a position in CL in Q3 2016 and has held it in 37 quarters since. The position peaked at $17.3M in Q1 2025. 383 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Crossmark Global Holdings held 146,708 shares of Colgate-Palmolive worth $13.5M as of Q2 2026.
- Crossmark Global Holdings bought 694 Colgate-Palmolive shares in Q2 2026, an estimated $60.7K.
- Colgate-Palmolive made up 0.17% of Crossmark Global Holdings's portfolio in Q2 2026, its #134 holding.
- Crossmark Global Holdings first reported a position in Colgate-Palmolive in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Colgate-Palmolive position peaked at $17.3M in Q1 2025.
- 383 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.